Previous research indicates that blocking the STAT3 signaling pathway can potentiate the efficacy of anti‐cancer therapies (Zuo et al. 2024; Zhong et al. 2024; Wang, Shi, et al. 2023). This evidence concerns the gene STAT3 and cancer.